You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.

Eli Lilly strikes $1.3 billion deal to buy gene-editing startup Verve Therapeutics, companies say ○

found 2025 › Jun › 17 (Tue) @ 11:25 UTC

a story from CNBC ⚠️ › Top News

○ Neutral overall

0.00 negativity

0.00 neutrality

0.00 positivity